Evaluation of [99MTc]glucarate as a breast cancer imaging agent : bench to bedside [abstract]

Abstract

The use of [99mTc]glucarate has been reported as an infarct-avid agent with the potential for very early detection of myocardial infarction. [99mTc]glucarate has also been postulated as an agent for non-invasive detection of tumors. The aim of the study was to develop a glucarate kit and evaluate [99mTc]glucarate as a potential cancer imaging agent in female SCID mice bearing human MDA-MB-435 breast tumors and in preliminary patient studies

Similar works

Full text

University of Missouri: MOspaceProvided a free PDF (195.62 KB)

10355/9228oai:mospace.umsystem.edu:10355/9228
Last time updated on November 17, 2016

This paper was published in University of Missouri: MOspace.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.